Filter your results
- 3
- 1
- 4
- 4
- 1
- 3
- 4
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimeticsCell Death and Differentiation, 2022, 29 (10), pp.2089-2104. ⟨10.1038/s41418-022-01001-3⟩
Journal articles
hal-03863787v1
|
||
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24, pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03437017v1
|
||
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24 (3), pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03425472v1
|
||
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24 (3), pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03372664v1
|